Cardiovascular stability with rapid intravenous infusion of ondansetron

Canadian Journal of Anaesthesia

Volumn 40, Issue 5, 1993, Pages 448-452

  Heyman, Julius S ^a   Young, Marie L ^a   Bagshaw, Roger I ^a   Levy, Warren J ^a   Geer, Ralph T ^a   Aukburg, Stanley J ^a   Joslyn, Alan E ^b   Conahan, Thomas J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Glaxo Inc ^*  (United States)

Author keywords

complications: haemodynamic, respiratory; serotonin: antagonists, ondansetron; vomiting: antiemetics

Indexed keywords

ONDANSETRON; SEROTONIN ANTAGONIST;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PREMEDICATION; PRIORITY JOURNAL;

ADULT; ANESTHESIA, GENERAL; BLOOD PRESSURE; DIASTOLE; FEMALE; HEART RATE; HUMAN; INJECTIONS, INTRAVENOUS; MIDDLE AGE; ONDANSETRON; OXYGEN; PLACEBOS; PREMEDICATION; RESPIRATION; SINGLE-BLIND METHOD; SUPPORT, NON-U.S. GOV'T; SYSTOLE; TIME FACTORS;

EID: 0027325394     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/BF03009516     Document Type: Article

References (25)

1. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors
2. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenteri radomized, double-blind, crossover study
3. Clinical studies with ondansetron in the control of radiation-induced emesis
4. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist
5. Antiemetic efficacy of ondansetron after outpatient laparoscopy
6. Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide
7. Ondansetron prevents postoperative nausea and vomiting in outpatient females
8. Cardiovascular reflexes and 5-hydroxytryptamine
9. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
10. A 5-hydroxytryptamine receptor in human atrium
11. The pharmacology and function of 5-HT3 receptors
12. 5 Hydroxytryptamine: a chameleon in the heart
13. The determination in plasma and pharmacokinetics of ondansetron
14. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors
15. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
16. Zacopride, a potent 5-HT3 antagonist
17. Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors
18. Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat
19. Presynaptic inhibition by serotonin of cardiac sympathetic transmission in dogs
20. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors
21. 5-Hydroxytryptamine3 receptors mediate tachycardia in conscious instrumented dogs
22. Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930
23. the effects of granisetron, ICS 205–930 and ondansetron on the visceral pain reflex induced by duodenal distension
24. Vascular pharmacology of 5-hydroxytryptamine in humans
25. Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205–930